Invizyne is revolutionizing biomanufacturing with its next-generation platform for the efficient, sustainable, and environmentally friendly production of fuels, foods, medicines, and other chemical products. While first-generation synthetic biology struggled with scalability and effectiveness, Invizyne’s pioneering Cell-Free Biomanufacturing liberates chemical manufacturing from biological constraints. Utilizing nature’s catalysts—enzymes—our technology expands enzyme-based conversions, leading to remarkable efficiency without toxic waste. Proven across sectors, Invizyne’s solutions produce next-generation natural ingredients, innovative pharmaceuticals, and specialty chemicals like renewable chemicals and sustainable aviation fuel (SAF), exemplified by our work with Isobutanol. Invizyne is committed to meeting the needs of the world’s growing population through transformative, sustainable chemical production.
Our board of directors comprises seasoned professionals with extensive expertise, driving exceptional strategic leadership and governance.
Explore our latest investor presentation to gain insights into Invizyne’s financial performance, strategic initiatives, and growth prospects. This comprehensive overview provides key information to help investors understand our market positioning and future opportunities.
Corporate Headquarters
750 Royal Oaks Drive,
Suite 106
Monrovia, CA 91016
(626) 415-1488
Investor Relations
Lasse Görlitz
VP of Communications
(858) 319-7135
press@invizyne.com
Transfer Agent
VStock Transfer, LLC.
18 Lafayette Place
Woodmere, New York 11598
(212) 828-8436